Does asthma control correlate with quality of life related to upper and lower airways? A real life study

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 6, 2009, Pages 937-943

  Braido, Fulvio ^a   Baiardini, I ^a   Balestracci, S ^a   Ghiglione, V ^a   Stagi, E ^b   Ridolo, E ^c   Nathan, R ^d   Canonica, G W ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d Asthma & Allergy Associates PC and Research Center   (United States)

Author keywords

Asthma; Comorbidity; Control; Quality of life; Real life; Rhinitis

Indexed keywords

ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; SALBUTAMOL; STEROID;

ADOLESCENT; ADULT; AGED; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; HAY FEVER; HUMAN; LOWER RESPIRATORY TRACT; MAJOR CLINICAL STUDY; MALE; PERENNIAL RHINITIS; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; STRUCTURED QUESTIONNAIRE; UPPER RESPIRATORY TRACT;

ADOLESCENT; ADULT; AGED; ASTHMA; COMORBIDITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 65549123190     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01932.x     Document Type: Article

References (32)

1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Revised 2006. Available at: http://ginasthma.com. Accessed 10 December 2007.
2. Bateman DE, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control Study. Am J Respir Crit Care Med 2004 170 : 836 844. (Pubitemid 39346477)
3. Bateman ED, Bousquet J, Keech ML, Busse WW, Clark TJ, Pedersen SE. The correlation between asthma control and health status: the GOAL study. Eur Respir J 2007 29 : 56 62. (Pubitemid 46091998)
4. Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol 1997 99 : 773 780. (Pubitemid 27091594)
5. Passalacqua G, Ciprandi G, Canonica GW. United airways disease: therapeutic aspects. Thorax 2000 55 : 26 27.
6. Passalacqua G, Ciprandi G, Canonica GW. The nose-lung interaction in allergic rhinitis and asthma: the United Airways Disease. Curr Opin 2001 1 : 7 13.
7. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994 94 : 182 188. (Pubitemid 24276655)
8. Stuck BA, Czaijkowski J, Hagner AE, Klimek L, Verse T, Hormann K et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol 2004 113 : 663 668. (Pubitemid 38530420)
9. Juniper EF, Stahl E, Doty RL et al. Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol 2005 115 : S390 S413. (Pubitemid 40326191)
10. Shedden A. Impact of nasal congestion on quality of life and work productivity in allergic rhinitis. Treat Respir Med 2005 4 : 438 445.
11. Bender BG, Fisher TL. Differential impacts of allergic rhinitis and allergy medication on childhood learning. Pediatr Asthma Allergy Immunol 1998 12 : 1 11. (Pubitemid 28334065)
12. Kirmaz C, Aydemir O, Bayrak P et al. Sexual dysfunction in patients with allergic rhinoconjunctivitis. Ann Allergy Asthma Immnunol 2005 95 : 525 529. (Pubitemid 43010477)
13. Bonini S, Bonini M, Bousquet J et al. Rhinitis and asthma in athletes: an ARIA document in collaboration with GALEN. Allergy 2006 61 : 681 692. (Pubitemid 43801401)
14. Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 2000 162 : 1391 1396.
15. Nathan RA, Sorkness CA, Kosinski M et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004 113 : 59 65. (Pubitemid 38096162)
16. Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006 117 : 549 556. (Pubitemid 43340217)
17. Baiardini I, Pasquali M, Giardini A, Specchia C, Passalacqua G, Venturi S et al. Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 2003 58 : 289 294. (Pubitemid 36566745)
18. Sullivan Pepe M. The statistical evaluation of medical tests for classification and prediction. Oxford, UK : Oxford University Press, 2003.
19. Hosmer DW Jr., Lemeshow S. Applied logistic regression, 2nd ed. New York, NY : Wiley, 2000.
20. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000 16 : 802 807. (Pubitemid 32049363)
21. Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006 6 : 13. (Pubitemid 43984043)
22. Canonica GW, Baena-Cagnani CE, Blaiss MS, Dahl R, Kaliner MA, Valovirta EJ et al. Unmet needs in asthma: Global Asthma Physician and Patient (GAPP) Survey: global adult findings. Allergy 2007 62 : 668 674. (Pubitemid 46763434)
23. Leynaert B, Bousquet J, Henry C, Liard R, Neukirch F. Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. Am J Respir Crit Care Med 1997 156 : 1413 1420. (Pubitemid 27505503)
24. Bottema RW, Reijmerink NE, Koppelman GH, Kerkhof M, Postma DS. Phenotype definition, age, and gender in the genetics of asthma and atopy. Immunol Allergy Clin North Am 2005 25 : 621 639. (Pubitemid 41551579)
25. Rodrigo GJ, Arcos JP, Nannini LJ, Neffen H, Broin MG, Contrera M et al. Reliability and factor analysis of the Spanish version of the asthma control test. Ann Allergy Asthma Immunol 2008 100 : 17 22.
26. Sullivan M, Karlsson J. The Swedish SF-36 health survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol 1998 51 : 1105 1113. (Pubitemid 28527166)
27. FDA. Draft guidance for industry on patient-reported outcome measures: use in medicinal product development to support labeling claims. Fed Regist 2006 71 : 5862 5863.
28. Committee for Medicinal Products for Human Use. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. Available at: http://www.emea.europa.eu/pdfs/human/ewp/1393104en.pdf (25 July 2005) (accessed 7 December 2006).
29. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008 336 : 924 926.
30. Baiardini I, Braido F, Tarantini F, Porcu A, Bonini S, Bousquet PJ et al. ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. Allergy 2008 63 : 660 669.
31. 2LEN review. Allergy 2008 63 : 1015 1030.
32. Bousquet J, van Cauwenberge PB, Khaltaev N, ARIA Workshop Group, WHO. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 108 : S1 S334.